We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Immunity Proteins Linked to Cancer

By LabMedica International staff writers
Posted on 31 Jul 2013
Print article
Image: Crystallography of Apolipoprotein B messenger RNA-editing enzyme (Image courtesy of Justin Steinfeld).
Image: Crystallography of Apolipoprotein B messenger RNA-editing enzyme (Image courtesy of Justin Steinfeld).
A set of proteins involved in immunity, which are supposed to defend the body, have the adverse effect of creating a large number of mutations in DNA.

These genetic mutations produce tumors in the human body, especially when these proteins transform, and can account for the majority of variations in some very aggressive cancers.

Scientists from the US National Institute of Environmental Health Sciences (Durham, NC, USA) examined 954,247 mutations within 2,680 cancer samples. Almost 70% of mutations resulted from the apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like cytidine deaminases (APOBEC) protein in some tumors. The investigators found that APOBEC mutations can outnumber all other mutations in some cancers, accounting for over two-thirds in some bladder, cervical, breast, head and neck, and lung tumors.

The APOBEC proteins are known to be of benefit, shutting down viruses that attack the body, but the scientists were surprised to find that they are also a detriment, mutating DNA. They found 498 total clusters in the 2,680 sequenced exomes from 14 different cancer types. In total, 218 cytosine- or guanine-coordinated clusters were identified, occurring in every cancer type analyzed except acute myeloid leukemia. Several cancer types showed high levels of the APOBEC mutation pattern as well as a wide variation among individual samples, which could reflect different biological pathways leading to carcinogenesis and the greatest range of variation was observed in breast cancer.

Dmitry A. Gordenin, PhD, a senior scientist and corresponding author of the study said, “The presence of APOBEC clusters in the genome of tumor cells indicates that APOBEC enzymes could also have caused many mutations across the genome.” His coauthor, Steven A. Roberts, added, “We hope that determining the environmental link to these mutations will lead to viable cancer prevention strategies.” The study was published on July 14, 2013, in the journal Nature Genetics.

Related Links:

US National Institute of Environmental Health Sciences


New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
PoC Testing Device
QuikRead
New
Automated Nucleic Acid Extraction Instrument
EX9600

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.